{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-100069","form_type":"8-K","ticker":"KRRO","cik":"0001703647","company_name":"Korro Bio, Inc.","filed_at":"2024-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.664719+00:00","generated_at":"2026-06-03T19:03:53.694287+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Korro Bio raises ~$70M in PIPE led by Deep Track Capital; pro-forma cash ~$236M","bullets":["PIPE of 1,249,283 shares at $56.00 each for gross proceeds of ~$70M.","Pro-forma cash and equivalents ~$236M, including existing $166.4M as of 12/31/23.","Lead investor Deep Track Capital; participants include Atlas, Blue Owl, NEA, Rock Springs, Tri Locum.","Proceeds to fund Phase 1/2 trial of KRRO-110 in AATD, expected completion in 2026.","Regulatory filing for first-in-human study of KRRO-110 anticipated H2 2024; interim readout H2 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-100069","json":"https://secwatch.observer/filing/0001193125-24-100069.json","markdown":"https://secwatch.observer/filing/0001193125-24-100069.md","text":"https://secwatch.observer/filing/0001193125-24-100069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703647/000119312524100069/0001193125-24-100069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703647/000119312524100069/d803577d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T19:03:53.694287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b9b7f45002043a34dd62498c215347194fc33fe2","claim":"Korro Bio, Inc. entered into Subscription Agreement with a number of institutional accredited investors valued at approximately $70.0 million (effective 2024-04-17).","evidence_excerpt":"On April 17, 2024, we entered into a subscription agreement with a number of institutional accredited investors pursuant to which we agreed to sell and issue in a private placement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1703647/000119312524100069/0001193125-24-100069-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a number of institutional accredited investors"},{"label":"Value","value":"approximately $70.0 million"},{"label":"Effective","value":"2024-04-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}